Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen
Authors:
- Young-Jin LeeYLYoung-Jin Lee
- Zhen-Yu WuZWZhen-Yu Wu
- Hee Jeong KimHKHee Jeong Kim
- Jong Won LeeJLJong Won Lee
- Il Yong ChungICIl Yong Chung
- Jisun KimJKJisun Kim
- Sae Byul LeeSLSae Byul Lee
- Byung Ho SonBSByung Ho Son
- Sung-Bae KimSKSung-Bae Kim
- Jae Ho JungJJJae Ho Jung
- Gyungyub GongGGGyungyub Gong
- Sei-Hyun AhnSASei-Hyun Ahn
Open Access
- 1 January 2020
- journal article
- research article
- Published by XMLink in Journal of Breast Cancer
- Vol. 23 (5) , 553-559
Abstract
Lee YJ, et al. J Breast Cancer. 2020 Oct;23(5):553-559. https://doi.org/10.4048/jbc.2020.23.e57Keywords
This publication has 19 references indexed in Scilit:
- Survival outcome of combined GnRH agonist and tamoxifen is comparable to that of sequential adriamycin and cyclophosphamide chemotherapy plus tamoxifen in premenopausal patients with early breast cancerMolecular and Clinical Oncology, 2019
- St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer TreatmentBreast Care, 2019
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateJournal of Clinical Oncology, 2019
- Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer RegistryJournal of Breast Cancer, 2018
- Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast CancerCancer Research and Treatment, 2016
- Role of Ovarian Function Suppression in Premenopausal Women with Early Breast CancerJournal of Breast Cancer, 2016
- Short term results from GHRH analogue use in pre-menopausal breast cancer in KoreaEuropean Journal of Surgical Oncology, 2009
- What Is the Role of Ovarian Ablation in the Management of Primary and Metastatic Breast Cancer Today?The Oncologist, 2004
- Quality of Life in Goserelin-Treated Versus Cyclophosphamide + Methotrexate + Fluorouracil–Treated Premenopausal and Perimenopausal Patients With Node-Positive, Early Breast Cancer: The Zoladex Early Breast Cancer Research Association Trialists GroupJournal of Clinical Oncology, 2003
- Side Effects of Adjuvant Endocrine Treatment in Premenopausal Breast Cancer Patients: A Prospective Randomized StudyJournal of Clinical Oncology, 2003